These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 29971627)

  • 1. Protein N-glycosylation alteration and glycolysis inhibition both contribute to the antiproliferative action of 2-deoxyglucose in breast cancer cells.
    Berthe A; Zaffino M; Muller C; Foulquier F; Houdou M; Schulz C; Bost F; De Fay E; Mazerbourg S; Flament S
    Breast Cancer Res Treat; 2018 Oct; 171(3):581-591. PubMed ID: 29971627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Under normoxia, 2-deoxy-D-glucose elicits cell death in select tumor types not by inhibition of glycolysis but by interfering with N-linked glycosylation.
    Kurtoglu M; Gao N; Shang J; Maher JC; Lehrman MA; Wangpaichitr M; Savaraj N; Lane AN; Lampidis TJ
    Mol Cancer Ther; 2007 Nov; 6(11):3049-58. PubMed ID: 18025288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low dose of 2-deoxy-D-glucose kills acute lymphoblastic leukemia cells and reverses glucocorticoid resistance via N-linked glycosylation inhibition under normoxia.
    Gu L; Yi Z; Zhang Y; Ma Z; Zhu Y; Gao J
    Oncotarget; 2017 May; 8(19):30978-30991. PubMed ID: 28415682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-Deoxy-D-glucose activates autophagy via endoplasmic reticulum stress rather than ATP depletion.
    Xi H; Kurtoglu M; Liu H; Wangpaichitr M; You M; Liu X; Savaraj N; Lampidis TJ
    Cancer Chemother Pharmacol; 2011 Apr; 67(4):899-910. PubMed ID: 20593179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined inhibition of glycolysis and AMPK induces synergistic breast cancer cell killing.
    Wu Y; Sarkissyan M; Mcghee E; Lee S; Vadgama JV
    Breast Cancer Res Treat; 2015 Jun; 151(3):529-39. PubMed ID: 25975952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Akt potentiates 2-DG-induced apoptosis via downregulation of UPR in acute lymphoblastic leukemia.
    DeSalvo J; Kuznetsov JN; Du J; Leclerc GM; Leclerc GJ; Lampidis TJ; Barredo JC
    Mol Cancer Res; 2012 Jul; 10(7):969-78. PubMed ID: 22692960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conversion of 2-deoxyglucose-induced growth inhibition to cell death in normoxic tumor cells.
    Liu H; Kurtoglu M; Cao Y; Xi H; Kumar R; Axten JM; Lampidis TJ
    Cancer Chemother Pharmacol; 2013 Jul; 72(1):251-62. PubMed ID: 23700291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the ROS/PI3K/AKT/HIF-1α/HK2 axis of breast cancer cells: Combined administration of Polydatin and 2-Deoxy-d-glucose.
    Zhang T; Zhu X; Wu H; Jiang K; Zhao G; Shaukat A; Deng G; Qiu C
    J Cell Mol Med; 2019 May; 23(5):3711-3723. PubMed ID: 30920152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic characterization of aggressive breast cancer cells exhibiting invasive phenotype: impact of non-cytotoxic doses of 2-DG on diminishing invasiveness.
    Fujita M; Imadome K; Somasundaram V; Kawanishi M; Karasawa K; Wink DA
    BMC Cancer; 2020 Sep; 20(1):929. PubMed ID: 32993545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycolytic inhibitor 2-deoxy-d-glucose attenuates SARS-CoV-2 multiplication in host cells and weakens the infective potential of progeny virions.
    Bhatt AN; Kumar A; Rai Y; Kumari N; Vedagiri D; Harshan KH; Chinnadurai V; Chandna S
    Life Sci; 2022 Apr; 295():120411. PubMed ID: 35181310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galloflavin, a new lactate dehydrogenase inhibitor, induces the death of human breast cancer cells with different glycolytic attitude by affecting distinct signaling pathways.
    Farabegoli F; Vettraino M; Manerba M; Fiume L; Roberti M; Di Stefano G
    Eur J Pharm Sci; 2012 Nov; 47(4):729-38. PubMed ID: 22954722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The anti-angiogenic action of 2-deoxyglucose involves attenuation of VEGFR2 signaling and MMP-2 expression in HUVECs.
    Chuang IC; Yang CM; Song TY; Yang NC; Hu ML
    Life Sci; 2015 Oct; 139():52-61. PubMed ID: 26285173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of 2-deoxyglucose on drug-sensitive and drug-resistant human breast cancer cells: toxicity and magnetic resonance spectroscopy studies of metabolism.
    Kaplan O; Navon G; Lyon RC; Faustino PJ; Straka EJ; Cohen JS
    Cancer Res; 1990 Feb; 50(3):544-51. PubMed ID: 2297696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular toxicity of the metabolic inhibitor 2-deoxyglucose and associated resistance mechanisms.
    Laussel C; Léon S
    Biochem Pharmacol; 2020 Dec; 182():114213. PubMed ID: 32890467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-Deoxy-D-glucose has distinct and cell line-specific effects on the survival of different cancer cells upon antitumor drug treatment.
    Maximchik P; Abdrakhmanov A; Inozemtseva E; Tyurin-Kuzmin PA; Zhivotovsky B; Gogvadze V
    FEBS J; 2018 Dec; 285(24):4590-4601. PubMed ID: 30375744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ifosfamide metabolite chloroacetaldehyde inhibits cell proliferation and glucose metabolism without decreasing cellular ATP content in human breast cancer cells MCF-7.
    Knouzy B; Dubourg L; Baverel G; Michoudet C
    J Appl Toxicol; 2010 Apr; 30(3):204-11. PubMed ID: 19774546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of the targeting properties of 2-deoxy-D-glucose-conjugated nanoparticles to breast cancer MDA-MB-231 cells and breast fibroblasts cells].
    Wang P; Shan XH; Xiong F; Gu N; Qian H; Fan Y; Wang YF
    Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):566-71. PubMed ID: 24314212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ATF4 mediates necrosis induced by glucose deprivation and apoptosis induced by 2-deoxyglucose in the same cells.
    León-Annicchiarico CL; Ramírez-Peinado S; Domínguez-Villanueva D; Gonsberg A; Lampidis TJ; Muñoz-Pinedo C
    FEBS J; 2015 Sep; 282(18):3647-58. PubMed ID: 26172539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Possible mechanism of the selective action of the inhibitors of glycolysis in the endothelial cells and the human carcinoma cells in the culture].
    Giliano NY; Bondarev GN; Konevega LV; Noskin LA; Zhurishkina EV; Alchinova IB
    Patol Fiziol Eksp Ter; 2014; (4):78-85. PubMed ID: 25980231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resveratrol augments ER stress and the cytotoxic effects of glycolytic inhibition in neuroblastoma by downregulating Akt in a mechanism independent of SIRT1.
    Graham RM; Hernandez F; Puerta N; De Angulo G; Webster KA; Vanni S
    Exp Mol Med; 2016 Feb; 48(2):e210. PubMed ID: 26891914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.